Cargando…

SYK Is Associated With Malignant Phenotype and Immune Checkpoints in Diffuse Glioma

Background: Diffuse glioma, the most common intracranial malignant tumor, is characterized by immunosuppression. The prognostic significance and potential therapeutic value of SYK remain obscure. Here, we explored the performance of SYK in predicting patient outcomes and as a therapeutic target. Met...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Quanwei, Wei, Min, Shen, Wenyue, Huang, Sheng, Fan, Jianfeng, Huang, He
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Genetics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9334658/ https://www.ncbi.nlm.nih.gov/pubmed/35910221 http://dx.doi.org/10.3389/fgene.2022.899883

Ejemplares similares

Three Immune-Associated Subtypes of Diffuse Glioma Differ in Immune Infiltration, Immune Checkpoint Molecules, and Prognosis
por: Zhou, Quanwei, et al.
Publicado: (2020)

CENPN Acts as a Novel Biomarker that Correlates With the Malignant Phenotypes of Glioma Cells
por: Wu, Hailong, et al.
Publicado: (2021)

Development of an Immune-Related LncRNA Prognostic Signature for Glioma
por: Cao, Yudong, et al.
Publicado: (2021)

Developing an Immune-Related Signature for Predicting Survival Rate and the Response to Immune Checkpoint Inhibitors in Patients With Glioma
por: Zhang, Sibin, et al.
Publicado: (2022)

Targeting immune checkpoints in malignant glioma
por: Zhang, Xuhao, et al.
Publicado: (2016)

Identification of three tumor antigens and immune subtypes for mRNA vaccine development in diffuse glioma
por: Zhou, Quanwei, et al.
Publicado: (2021)

Corrigendum: Developing an immune-related signature for predicting survival rate and the response to immune checkpoint inhibitors in patients with glioma
por: Zhang, Sibin, et al.
Publicado: (2022)

Prognostic biomarker SYK and its correlation with immune infiltrates in glioma
por: Wang, Changxin, et al.
Publicado: (2023)

An Integrated Immune-Related Bioinformatics Analysis in Glioma: Prognostic Signature’s Identification and Multi-Omics Mechanisms’ Exploration
por: Fan, Xin, et al.
Publicado: (2022)

Prognostic RNA-editing signature predicts immune functions and therapy responses in gliomas
por: He, Yi, et al.
Publicado: (2023)

Gene set-based identification of two immune subtypes of diffuse large B cell lymphoma for guiding immune checkpoint blocking therapy
por: Li, Zhe, et al.
Publicado: (2022)

Multi-Omics Analysis Based on Genomic Instability for Prognostic Prediction in Lower-Grade Glioma
por: Cao, Yudong, et al.
Publicado: (2022)

Targeting macrophage Syk enhances responses to immune checkpoint blockade and radiotherapy in high-risk neuroblastoma
por: Rohila, Deepak, et al.
Publicado: (2023)

Molecular Subtypes Based on the Stemness Index Predict Prognosis in Glioma Patients
por: Tan, Jun, et al.
Publicado: (2021)

Syk inhibitors in clinical development for hematological malignancies
por: Liu, Delong, et al.
Publicado: (2017)

Dissecting the Role of Immune Checkpoint Regulation Patterns in Tumor Microenvironment and Prognosis of Gastric Cancer
por: Zhen, Zili, et al.
Publicado: (2022)

The role of costimulatory molecules in glioma biology and immune microenvironment
por: Wang, Ji, et al.
Publicado: (2022)

Emerging Role and Mechanism of circRNAs in Pediatric Malignant Solid Tumors
por: Shen, Qiyang, et al.
Publicado: (2022)

The clinical features, prognostic significance, and immune heterogeneity of CD37 in diffuse gliomas
por: Yan, Xuejun, et al.
Publicado: (2021)

Comprehensive Analysis of Pyroptosis-Associated in Molecular Classification, Immunity and Prognostic of Glioma
por: Chen, Peng, et al.
Publicado: (2022)

High expression of ZFP36L2 correlates with the prognosis and immune infiltration in lower-grade glioma
por: Zhou, Min, et al.
Publicado: (2022)

Identification of Dysregulated Competitive Endogenous RNA Networks Driven by Copy Number Variations in Malignant Gliomas
por: Xu, Jinyuan, et al.
Publicado: (2019)

Pan-glioma analyses reveal species- and tumor-specific regulation of neuron-glioma synapse genes by lncRNAs
por: Xiong, Wei, et al.
Publicado: (2023)

CD96, a new immune checkpoint, correlates with immune profile and clinical outcome of glioma
por: Liu, Fangkun, et al.
Publicado: (2020)

A Previously Unknown Unique Challenge for Inhibitors of SYK ATP-Binding Site: Role of SYK as A Cell Cycle Checkpoint Regulator()
por: Uckun, Fatih M., et al.
Publicado: (2014)

Systematically Dissecting the Function of RNA-Binding Proteins During Glioma Progression
por: Wang, Jianjun, et al.
Publicado: (2020)

ESPL1 Is a Novel Prognostic Biomarker Associated With the Malignant Features of Glioma
por: Liu, Zhendong, et al.
Publicado: (2021)

Potential predictive value of circulating tumor DNA (ctDNA) mutations for the efficacy of immune checkpoint inhibitors in advanced triple-negative breast cancer
por: Tan, Qiaorui, et al.
Publicado: (2023)

GBP2 as a potential prognostic predictor with immune-related characteristics in glioma
por: Li, Ren, et al.
Publicado: (2022)

Interferon gamma-related gene signature based on anti-tumor immunity predicts glioma patient prognosis
por: Zhang, Zhe, et al.
Publicado: (2023)

The Predictive Role of Immune Related Subgroup Classification in Immune Checkpoint Blockade Therapy for Lung Adenocarcinoma
por: Yu, Xiaozhou, et al.
Publicado: (2021)

Cuproptosis-related immune checkpoint gene signature: Prediction of prognosis and immune response for hepatocellular carcinoma
por: Cong, Tianhao, et al.
Publicado: (2022)

Current Progress and Future Perspectives of Immune Checkpoint in Cancer and Infectious Diseases
por: Cai, Xin, et al.
Publicado: (2021)

A prognostic pyroptosis-related LncRNA classifier associated with the immune landscape and therapy efficacy in glioma
por: Zhong, Jiasheng, et al.
Publicado: (2022)

Prognostic risk of immune-associated signature in the microenvironment of brain gliomas
por: Tao, Yaling, et al.
Publicado: (2023)

EFNA3 Is a Prognostic Biomarker Correlated With Immune Cell Infiltration and Immune Checkpoints in Gastric Cancer
por: Zheng, Peng, et al.
Publicado: (2022)

A Gene Panel for Early Identification of Future Responders to Immune Checkpoint Blockade
por: Panda, Anshuman, et al.
Publicado: (2022)

MCM10 is a Prognostic Biomarker and Correlated With Immune Checkpoints in Ovarian Cancer
por: Wu, Zhenzhen, et al.
Publicado: (2022)

Construction and validation of an angiogenesis-related gene expression signature associated with clinical outcome and tumor immune microenvironment in glioma
por: Hu, Tianhao, et al.
Publicado: (2022)

Syk-coupled C-type lectins in immunity
por: Kerrigan, Ann M., et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_h22mmtcvej6fu4gpgq46e4i5aq